Silver Spring, Maryland–(ENEWSPF)–August 14, 2014. The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to treat patients with persistent, recurrent or late-stage (metastatic) cervical cancer.
FDA Approves Avastin to Treat Patients with Aggressive and Late-stage Cervical Cancer
More in Health and Fitness:
